TYP 0.00% 1.9¢ tryptamine therapeutics limited

Codiak ($800mil market capitalisation), page-167

  1. 4,283 Posts.
    lightbulb Created with Sketch. 13
    Im happy selling out at circa $100m market cap. There is a reason why CDAK has a higher market cap then EX1 and that's because it has Goldman Sachs backing. Atm Im concerned about stretched valuations with equity markets globally so I can see some big retraces happening in the very near future and with that I can also see a capital raise coming very soon for EX1 although I could be wrong there. Also some private EV startups are ahead of EX1 so am happy with the returns. Happy to reenter if this retraces and happy to see long term holders gain massively GLTAH
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $20.69M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
3 787913 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 711736 4
View Market Depth
Last trade - 11.03am 11/09/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.